Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada


New Substances Notification Regulations (Organisms)

Version of the schedule from 2006-03-22 to 2018-02-01:

SCHEDULE 4(Subsection 3(6) and paragraph 6(b))Information Required in Respect of Micro-organisms Manufactured at the Site from Which They Were Isolated for Introduction into the Same Site

  • 1 The following information in respect of the micro-organism:

    • (a) its identification and the information substantiating the identification;

    • (b) its infectivity, pathogenicity to non-human species, toxicity and toxigenicity; and

    • (c) a description of the reasonably expected by-products following introduction.

  • 2 The following information in respect of the manufacture of the micro-organism:

    • (a) data to substantiate that the micro-organism was isolated from the site of introduction;

    • (b) the viability of the micro-organism in the formulation;

    • (c) an estimation of the quantity of the micro-organism that will be manufactured;

    • (d) a description of the equipment and methods of manufacture and of quality control and quality assurance procedures; and

    • (e) a description of the procedures for the treatment and disposal of wastes containing the micro-organism.

  • 3 The location and a map of the site of introduction.

  • 4 The following information in respect of the introduction of the micro-organism:

    • (a) its intended use;

    • (b) the start date and duration;

    • (c) a description of the procedures for its introduction including

      • (i) the method of application,

      • (ii) the quantity, frequency and duration of application, and

      • (iii) any activities associated with the introduction; and

    • (d) a description of any confinement procedures and biosafety conditions for the micro-organism at the site of introduction, and a description of their effectiveness.

  • 5 The following information in respect of the human health effects of the micro-organism:

    • (a) any documented involvement of the micro-organism in adverse human health effects and a description of the characteristics of the micro-organism that distinguish it from known pathogens; and

    • (b) the estimated number of persons who may become exposed and the degree of their exposure to the micro-organism.

  • 6 All other information and test data in respect of the micro-organism that are relevant to identifying hazards to the environment and human health and that are in the person’s possession or to which the person ought reasonably to have access.

  • 7 The identification of other government agencies, either outside or within Canada, that the person has notified of the manufacture or importation of the micro-organism, and the purpose of that notification.

  • 8 A description or specification of the test procedures followed in developing the test data, including the test methods, reference substances and quality control and quality assurance procedures.

Date modified: